Pneumonia Vaccine for Seniors: Essential Facts for Better Protection

Nearly one million Americans aged 65 and older are hospitalized with pneumonia each year, and about 30 percent of treated seniors die from it. The disease is a serious health threat for older adults.

Pneumococcal bacteria cause more than 900,000 infections annually in the United States, according to the Centers for Disease Control and Prevention (CDC). Half of the deaths occur in people 65 and older. In 2024, the CDC lowered its vaccination recommendation from age 65 to age 50, after finding that 40 percent of adults in that age group have underlying medical conditions that increase their risk of severe infection.

Pneumococcal vaccines are the most effective way to prevent these infections. This guide covers the latest vaccine recommendations, how they work, and how to decide if vaccination makes sense for you.

• Understanding pneumonia risk after 50
• Latest pneumonia vaccine guidelines for seniors
• Making your vaccination decision
• Conclusion
• FAQs

Understanding pneumonia risk after 50

Adults 50 and older are 6.4 times more likely to get pneumococcal pneumonia than younger adults. Those over 65 are 10 times more likely to be hospitalized from it.

Several physical changes make older lungs more vulnerable. The immune system weakens with age, lung tissue becomes less elastic, and respiratory muscles lose strength. Together, these changes make infection more likely.

Chronic diseases amplify the risk dramatically. COPD, heart disease, diabetes, and chronic kidney disease all increase the chances of severe pneumonia. About 80 percent of pneumonia patients over 75 have at least one chronic condition, with respiratory disease being the most common at 54 percent.

Poor nutrition is another factor. Studies show 77 percent of elderly pneumonia patients are malnourished. Low protein and reduced muscle mass contribute to higher death rates during hospital stays.

The effects don't end when someone leaves the hospital. Survivors report 16 percent lower quality of life in the year after discharge. Within one year, 40 percent of seniors hospitalized with pneumonia die, compared to 1.2 percent of those without the infection.

Older adults often show different symptoms than younger people. Watch for:

• Mental confusion or loss of consciousness
• Breathing faster than 30 breaths per minute
• Heart rate above 120 beats per minute
• Low blood pressure
• Fever above 104°F or below 95°F

Pneumonia is the leading infectious disease killer among elderly people. Knowing these age-specific warning signs can make a real difference.

Latest pneumonia vaccine guidelines for seniors

The CDC now recommends pneumococcal vaccination starting at age 50, down from the previous recommendation of 65. The change is based on research showing that 40 percent of people aged 50 to 64 have medical conditions that put them at higher risk of severe infection.

Two main types of pneumococcal vaccine are available. Pneumococcal Conjugate Vaccines (PCVs) include PCV15, PCV20, and the newer PCV21. The other type is the Pneumococcal Polysaccharide Vaccine (PPSV23).

For unvaccinated adults 50 and older, the CDC recommends PCV15, PCV20, or PCV21. If you get PCV15, you'll need a PPSV23 shot one year later. PCV20 or PCV21 provide complete protection on their own.

These vaccines work well. PPSV23 prevents 60 to 70 percent of serious pneumococcal infections caused by vaccine strains. Studies of adults 65 and older show PCV13 provides:

• 75% protection against serious pneumococcal infection from vaccine strains
• 46% protection against pneumococcal pneumonia from vaccine strains

• 45% protection against non-bacteremic pneumococcal pneumonia from vaccine strains

Most healthy adults develop protective antibodies within 2 to 3 weeks after PPSV23 vaccination. Older adults and those with chronic conditions may take longer. These antibody levels usually last at least 5 years.

The newer vaccines cover more bacterial strains. PCV21, approved in 2024, protects against 21 types of pneumococcal bacteria. PCV20 covers 20 types, PCV15 covers 15 types, and PPSV23 protects against 23 types.

The CDC updated these recommendations because of growing evidence about pneumococcal disease risk in older adults. If you're 50 or older, talk to your doctor about which vaccine is right for you.

Making your vaccination decision

Your doctor is the best person to help you decide whether to get vaccinated. Consider these key factors:

Medical history and risk factors: Your age, current health conditions, and past vaccinations all matter. Nursing home residents face higher exposure to pneumococcal bacteria and may need extra protection.

Timing: Don't get vaccinated if you have a fever. Minor illnesses won't delay vaccination. Your doctor can coordinate the pneumonia vaccine with your flu shot or other immunizations.

Cost: Medicare Part B covers pneumococcal vaccines at no cost through participating providers. Most Medicaid and private insurance plans do the same.

Past vaccinations: If you received an older pneumococcal vaccine (PCV7 or PCV13), ask your doctor whether you need additional doses. Research suggests adults 65 and older may benefit from PCV20 or PCV21 five years after finishing an initial series.

Where you live: Vaccination needs depend partly on your location. If you live in or travel to areas with low childhood vaccination rates, you may need extra protection.

A strong recommendation from your doctor significantly increases the chance you'll get vaccinated. Good doctors use these steps:

• Explain why the vaccine matters for your specific situation
• Share stories of patients who benefited from vaccination
• Answer your concerns directly
• Remind you what protection means
• Discuss the risks of not being vaccinated

Bring a list of your current medications and supplements to your vaccination appointment. This helps your doctor make sure the vaccine is safe for you.

Conclusion

Pneumonia strikes nearly one million older Americans every year. The CDC lowered the recommended vaccination age to 50 because early protection saves lives. The newer vaccines PCV20 and PCV21 protect against more bacterial strains than older options, giving seniors better defense.

Talk to your doctor about your personal health history and the right timing for your shot. Medicare Part B covers the cost through participating providers, so cost won't stand in your way.

Pneumococcal vaccines are among the most effective tools for preventing serious infections in older adults. Ask your doctor which vaccine is right for you based on your health. The benefits far outweigh the small risks of side effects.

FAQs

Q1. At what age should I consider getting the pneumonia vaccine? The CDC recommends pneumococcal vaccination starting at age 50. This is a change from the previous recommendation of 65, based on evidence that many people in their 50s and early 60s have conditions that increase their infection risk.

Q2. What types of pneumonia vaccines are available? Two main types exist: Pneumococcal Conjugate Vaccines (PCVs)—which include PCV15, PCV20, and PCV21—and the Pneumococcal Polysaccharide Vaccine (PPSV23). Your doctor can help you decide which is best for you.

Q3. What side effects should I expect? Most side effects are mild and brief. Common reactions include pain where the shot was given and headache. Serious side effects are rare, but mention any concerns to your doctor beforehand.

Q4. How well do these vaccines work? Studies show they're highly effective. PPSV23 prevents 60 to 70 percent of serious pneumococcal infections, while PCV13 provides 75 percent protection against serious disease in adults 65 and older.

Q5. Does Medicare cover the pneumonia vaccine? Yes. Medicare Part B covers pneumococcal vaccines at no cost when your healthcare provider accepts Medicare. This removes cost as a barrier for most seniors.